The first generation of CSF biomarkers for Alzheimer disease comprises those that measure the component proteins of the disease’s signature pathologic lesions. They have been explored for almost 15 ...
A technology that diagnoses various diseases, including Alzheimer’s and Parkinson’s, using just a few drops of blood from a ...
In clinical research, a first-time finding may rouse intrigue, but it’s generally independent confirmations of the data that give them potential to leave an indelible mark. That’s why a study of ...